Medtronic's PulseSelect PFA System Shows 98% Pulmonary Vein Isolation In Atrial Fibrillation Study

(RTTNews) - Medtronic plc (MDT) announced that clinical study results demonstrated a high rate of durable lesion formation using the PulseSelect Pulsed Field Ablation (PFA) System in the treatment of atrial fibrillation (Afib). Invasive remapping conducted approximately two months post-ablation revealed durable isolation in 98% of pulmonary veins (PV), with 96% of patients achieving complete isolation of all veins.

Atrial fibrillation (Afib) is one of the most common and undertreated heart rhythm disorders, affecting more than 60 million people worldwide.

For More Such Health News, visit rttnews.com.